<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19963">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02847013</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00005133</org_study_id>
    <nct_id>NCT02847013</nct_id>
  </id_info>
  <brief_title>The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <brief_summary>
    <textblock>
      This present investigation aims to determine whether a transversus abdominous plane(TAP)
      block, utilizing liposomal bupivacaine (Exparel), at the conclusion of a cesarean section
      decreases post-operative pain. The hypothesis is that performance of the TAP block with
      liposomal bupivacaine will decrease post-operative narcotic use.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative narcotic use</measure>
    <time_frame>initial 48 hours postoperatively</time_frame>
    <description>Patient use of standard postoperative narcotics (percocet) will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective pain scores using 1-10 VAS system</measure>
    <time_frame>initial 48 hours postoperatively</time_frame>
    <description>Subjective pain scores using 1-10 VAS system will be measured</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After completion of surgery with closer of skin incision a TAP block will be performed. On confirmation of entering the fascial plane, 20cc of Normal saline will be injected after negative aspiration. That will complete the intervention. 20 patients will be in this arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After completion of surgery with closer of skin incision a TAP block will be performed. On confirmation of entering the fascial plane, Liposomal bupivacaine 0.33% (10 ml diluted to 20 ml using sterile normal saline) will be injected after negative aspiration. That will complete the intervention. 20 patients will be in this arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TAP block with Liposomal bupivacaine</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP block with normal saline</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;18 years of age

          -  Scheduled cesarean section with or without bilateral tubal ligation

          -  Planned performance of a Pfannenstiel incision

          -  Patients are schedule to have a cesarean section with a member of the Women's Health
             or Maternal and Fetal Medicine Departments at Penn State University Hershey S.
             Medical Center

        Exclusion Criteria:

          -  History of opioid use

          -  History of chronic pain syndrome

          -  Use of general anesthesia during cesarean delivery

          -  Postoperative SICU admission

          -  Postpartum hemorrhage (defined as an Estimated Blood Loss of greater then 1,000mL
             upon completion of the cesarean section)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephen Wagner</last_name>
    <phone>7172837796</phone>
    <email>swagner2@hmc.psu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jamiey Pauli</last_name>
    <phone>717 531 8142</phone>
    <email>jpauli@hmc.psu.edu</email>
  </overall_contact_backup>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 26, 2016</lastchanged_date>
  <firstreceived_date>July 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Stephen Wagner</investigator_full_name>
    <investigator_title>OB/GYN Resident</investigator_title>
  </responsible_party>
  <keyword>Postcesarean Section</keyword>
  <keyword>Postoperative</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
